About MSPharma
MSPharma is a company based in Amman (Jordan) founded in 1989. MSPharma has raised $45 million across 2 funding rounds from investors including International Finance Corporation and EBRD. MSPharma has completed 1 acquisition, including Genepharm. MSPharma offers products and services including Generic Medicines, Specialty Medicines, and Biotech Products.
- Headquarter Amman, Jordan
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$45 M (USD)
in 2 rounds
-
Latest Funding Round
$45 M (USD), Private Equity Round
May 16, 2017
-
Investors
International Finance Corporation
& 1 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MSPharma
MSPharma offers a comprehensive portfolio of products and services, including Generic Medicines, Specialty Medicines, and Biotech Products.
Cost-effective equivalents of branded drugs for various treatments
Advanced therapies for specific diseases and conditions
Innovative biological medicines targeting oncology and other areas
People of MSPharma
Unlock access to complete
Funding Insights of MSPharma
MSPharma has successfully raised a total of $45M across 2 strategic funding rounds. The most recent funding activity was a Private Equity Round of $45 million completed in May 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in MSPharma
MSPharma has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include International Finance Corporation and EBRD.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Corporate advisory services are provided across multiple sectors.
|
Locked | Locked | Locked | |
|
IFC is focused on private sector development in emerging markets.
|
Locked | Locked | Locked |
Investor details for MSPharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MSPharma
MSPharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Genepharm.
Investment portfolio details for MSPharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Generic drugs are manufactured in Pallini, Greece.
|
Locked | Locked | 1967 | Locked |
Complete acquisition details for MSPharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - MSPharma
Detailed financials for MSPharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mspharma Comparisons
Peer comparison for MSPharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MSPharma
Detailed competitors of MSPharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mspharma
Complete news archive for MSPharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MSPharma
MSPharma was founded in 1989 and raised its 1st funding round 26 years after it was founded.
MSPharma is headquartered in Amman, Jordan.
MSPharma is a funded company, having raised a total of $45M across 2 funding rounds to date.
MSPharma was founded in 1989 in Amman, Jordan, within the pharmaceutical sector. Generic formulations are produced for therapeutic areas such as cardiovascular, central nervous system, respiratory, infections, endocrine, obstetrics, gynecology, urinary tract, and musculoskeletal conditions. Over-the-counter products are also manufactured, including gastrointestinal treatments, medico-cosmetics, feminine healthcare, baby care, cold and cough remedies, pain relief, diagnostics, food supplements, nutraceuticals, and multivitamins. Operations focus on standard pharmaceutical manufacturing processes.
MSPharma offers Generic Medicines, Specialty Medicines, and Biotech Products.
MSPharma has made 1 acquisition, including Genepharm.
MSPharma has 2 investors. Key investors include International Finance Corporation, and EBRD.